Timofey D Lebedev (Timofey Lebedev)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alesya M Mikheeva, Mikhail A Bogomolov, Valentina A Gasca, Mikhail V Sementsov, Pavel V Spirin, Vladimir S Prassolov, Timofey D Lebedev
Improving the power of drug toxicity measurements by quantitative nuclei imaging. Cell death discovery 10 (1) (2024)
Alesya M Mikheeva, Mikhail A Bogomolov, Valentina A Gasca, Mikhail V Sementsov, Pavel V Spirin, Vladimir S Prassolov, Timofey D Lebedev
Improving the power of drug toxicity measurements by quantitative nuclei imaging. Cell death discovery 10 (1) (2024)
Alesya M Mikheeva, Mikhail A Bogomolov, Valentina A Gasca, Mikhail V Sementsov, Pavel V Spirin, Vladimir S Prassolov, Timofey D Lebedev
Improving the power of drug toxicity measurements by quantitative nuclei imaging. Cell death discovery 10 (1) (2024)
Alesya M Mikheeva, Mikhail A Bogomolov, Valentina A Gasca, Mikhail V Sementsov, Pavel V Spirin, Vladimir S Prassolov, Timofey D Lebedev
Improving the power of drug toxicity measurements by quantitative nuclei imaging. Cell death discovery 10 (1) (2024)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Ksenia Glumakova, Georgy Ivanov, Valeria Vedernikova, Elena Y Shyrokova, Timofey D Lebedev, Andrei Stomakhin, Anastasia Zenchenko, Vladimir E Oslovsky, Mikhail S Drenichev, Vladimir S Prassolov, Pavel V Spirin
Nucleoside Analog 2',3'-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1. Pharmaceutics 15 (10) (2023)
Dmitri Kamashev, Nina Shaban, Timofey D Lebedev, Vladimir S Prassolov, Maria Suntsova, Mikhail Raevskiy, Nurshat Gaifullin, Marina Sekacheva, Andrew Garazha, Elena V Poddubskaya, Maxim I Sorokin, Anton Buzdin
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways. Cells 12 (16) (2023)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Timofey D Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12 (6) (2023)
Nikolay A Bondarev, Karina Ivanenko, Elmira Khabusheva, Timofey D Lebedev, Ilya Manukhov, Vladimir Prassolov
MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation. International journal of molecular sciences 23 (21) (2022)
Pavel Spirin, Elena Shyrokova, Timofey D Lebedev, Elmira Vagapova, Polina Smirnova, Alexey Kantemirov, Sergey A Dyshlovoy, Gunhild von Amsberg, Maxim Zhidkov, Vladimir Prassolov
Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death. Marine drugs 19 (9) (2021)
Timofey D Lebedev, Elmira Vagapova, Pavel Spirin, Petr Rubtsov, Olga Astashkova, Alesya Mikheeva, Maxim Sorokin, Uliana Vladimirova, Maria Suntsova, Dmitry Konovalov, Alexander Roumiantsev, Carol Stocking, Anton Buzdin, Vladimir Prassolov
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes. Oncogene 40 (44) (2021)
Elmira Vagapova, Alexander Burov, Daria Spasskaya, Timofey D Lebedev, Tatiana Astakhova, Pavel V Spirin, Vladimir Prassolov, Vadim Karpov, Alexey V Morozov
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses. Cells 10 (5) (2021)

Timofey D Lebedev.css-eqlu8i{font-size:small;padding-left:4px;} (Timofey Lebedev)

Publication Activity (10 Years)

Top Topics

Top Venues

Timofey D Lebedev (Timofey Lebedev)